AnaptysBio Inc expected to post a loss of $1.63 a share - Earnings Preview

AnaptysBio

26/02/2024 11:10

* AnaptysBio Inc  ANAB.OQ   ANAB.O  is expected to show a
fall in
quarterly revenue when it reports  results on February 28
(estimated) for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report a
70.1% decrease in revenue to $2.033 million from $6.81 million a
year ago, according to the mean estimate from 6 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for AnaptysBio Inc is for a
loss
of $1.63 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AnaptysBio
Inc is
$30.00​, above​ its last closing price of $25.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -1.80       -1.79      -1.41     Beat    21.4
 Jun. 30 2023  -1.83       -1.70      -1.50     Beat    11.6
 Mar. 31 2023  -1.08       -1.05      -1.58     Missed  -50.8​
 Dec. 31 2022  -0.96       -0.96      -0.93     Beat    2.8
 ​​Sep.        -0.65       -0.72      -1.18     Missed  -63.1
 30 2022                                                
 Jun. 30 2022  -0.89       -1.02      -1.15     Missed  -12.6​
 Mar. 31 2022  -1.02       -0.99      -1.31     Missed  -31.7
 Dec. 31 2021  5.54        2.57       -1.13     Missed  -143.9
 This summary was machine generated February 26 at 11:10 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)